Literature DB >> 18204959

Treatment and prevention of osteoporosis.

Jaroslav Blahos1.   

Abstract

Osteoporosis is recognized as a major health threat. The number of patients will certainly grow with the aging of the population. While preventive strategies, such as calcium, vitamin D, exercise and reduced risk factors may diminish the impact of menopause and age-regulated bone loss, many patients will become candidates for pharmacologic therapy. A variety of options are available, including HRT, bisphosphonates, SERMs, calcitonin, strontium ranelate, teriparatid. New forms of treatment are appearing on the horizon, such as monoclonal antibodies, nitrates, beta-blockers and Cathepsin K inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18204959     DOI: 10.1007/s10354-007-0486-7

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  8 in total

1.  Osteonecrosis of the jaw--do bisphosphonates pose a risk?

Authors:  John P Bilezikian
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

2.  Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.

Authors:  Pierre J Marie
Journal:  Curr Opin Rheumatol       Date:  2006-06       Impact factor: 5.006

3.  Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.

Authors:  Paul D Miller; Michael R McClung; Liviu Macovei; Jacob A Stakkestad; Marjorie Luckey; Bernard Bonvoisin; Jean-Yves Reginster; Robert R Recker; Claire Hughes; E Michael Lewiecki; Dieter Felsenberg; Pierre D Delmas; David L Kendler; Michael A Bolognese; Nicole Mairon; Cyrus Cooper
Journal:  J Bone Miner Res       Date:  2005-03-14       Impact factor: 6.741

4.  Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.

Authors:  Elizabeth Barrett-Connor; Lori Mosca; Peter Collins; Mary Jane Geiger; Deborah Grady; Marcel Kornitzer; Michelle A McNabb; Nanette K Wenger
Journal:  N Engl J Med       Date:  2006-07-13       Impact factor: 91.245

5.  Risk factors for fractures of the proximal humerus: results from the EPIDOS prospective study.

Authors:  Sun H Lee; Patricia Dargent-Molina; Gérard Bréart
Journal:  J Bone Miner Res       Date:  2002-05       Impact factor: 6.741

6.  Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Authors:  Garnet L Anderson; Marian Limacher; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry Black; Denise Bonds; Robert Brunner; Robert Brzyski; Bette Caan; Rowan Chlebowski; David Curb; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan Hendrix; Barbara V Howard; Judith Hsia; Allan Hubbell; Rebecca Jackson; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis Kuller; Andrea Z LaCroix; Dorothy Lane; Robert D Langer; Norman Lasser; Cora E Lewis; JoAnn Manson; Karen Margolis; Judith Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Cheryl Ritenbaugh; John Robbins; Jacques E Rossouw; Gloria Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Robert Wallace; Sylvia Wassertheil-Smoller
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

7.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  Dennis M Black; Pierre D Delmas; Richard Eastell; Ian R Reid; Steven Boonen; Jane A Cauley; Felicia Cosman; Péter Lakatos; Ping Chung Leung; Zulema Man; Carlos Mautalen; Peter Mesenbrink; Huilin Hu; John Caminis; Karen Tong; Theresa Rosario-Jansen; Joel Krasnow; Trisha F Hue; Deborah Sellmeyer; Erik Fink Eriksen; Steven R Cummings
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

8.  Denosumab in postmenopausal women with low bone mineral density.

Authors:  Michael R McClung; E Michael Lewiecki; Stanley B Cohen; Michael A Bolognese; Grattan C Woodson; Alfred H Moffett; Munro Peacock; Paul D Miller; Samuel N Lederman; Charles H Chesnut; Douglas Lain; Alan J Kivitz; Donna L Holloway; Charlie Zhang; Mark C Peterson; Pirow J Bekker
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245

  8 in total
  4 in total

1.  Metabolic bone diseases: basic and clinical aspects.

Authors:  Jaroslava Wendlová
Journal:  Wien Med Wochenschr       Date:  2007

2.  Parathyroid hormone analogues in the therapy of osteoporosis.

Authors:  Markus Müller; Peter Pietschmann
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

3.  Structural and cellular features in metaphyseal and diaphyseal periosteum of osteoporotic rats.

Authors:  Wei Fan; Stefan A W Bouwense; Ross Crawford; Yin Xiao
Journal:  J Mol Histol       Date:  2010-03-16       Impact factor: 2.611

4.  A Pilot Study for Discovering Candidate Genes of Chromosome 18q21 in Methamphetamine Abusers: Case-control Association Study.

Authors:  Byung Dae Lee; Je Min Park; Young Min Lee; Eun Soo Moon; Hee Jeong Jeong; Young In Chung; Hyo Deog Rim
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-04-24       Impact factor: 2.582

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.